GLP1 Receptor Agonist Liraglutide Is an Effective Therapeutic Option for Perioperative Glycemic Control in Type 2 Diabetes within Enhanced Recovery After Surgery (ERAS) Protocols
Year: 2018
Type: article
Study design: Clinical Trial
Source: European Surgical Research
DOI: 10.1159/000494768
Authors: Shizuka Kaneko, Youhei Ueda, Yumiko Tahara
Institution: Takatsuki Red Cross Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: liraglutide, GLP-1 receptor agonists, type 2 diabetes, enhanced recovery after surgery, perioperative glycemic control, insulin therapy, elective surgery, visceral fat, body composition, sliding scale insulin, surgical stress response, postoperative recovery, drug safety and efficacy, orthopedic surgery, hepatectomy
Open Access status: closed
Funder: Johnson and Johnson
OpenAlex ID: W2905560533
